With grant funding from governments at multiple levels in Canada, Entos Pharmaceuticals is looking to plant roots at a CAD $198.5 million ($137.2 million) R&D and manufacturing hub in Edmonton. | The ...

Merck says the expansion in Durham is part of more than $12 billion the company has invested in U.S. manufacturing and ...

Unveiling of the new factory comes as Merck and other pharma companies face pressure to reshore manufacturing back to the U.S ...

Eli Lilly plans to launch its diabetes and weight-loss drug, Mounjaro, in emerging markets such as India, Brazil, and Mexico in 2025. The expansion leverages growing demand in populous countries ...

Eli Lilly plans to launch Mounjaro, its blockbuster diabetes drug, in countries like China, India, Brazil and Mexico by 2026, ...

The Trump administration has courted at least $3 trillion in investment and trade commitments since Trump's inauguration.

Eli Lilly wants the most optimal locations to host its new manufacturing facilities in the U.S.—and it’s open to pitche | Eli ...

Alex Marlow while guest-hosting Charlie Kirk's show praises “the level of 4D chess Trump is playing” ...

Eli Lilly also responded to the President's tariff warnings by investing $27 billion to construct four manufacturing ...

With this latest announcement, Lilly has committed to investing more than $50 billion in U.S. manufacturing since 2020.

California made a bold announcement that it would manufacture a state-branded, low-cost insulin. It still is not here.

Here's a rundown of some of the multibillion-dollar spending pledges made by companies since President Trump took office.